ZFP Therapeutic

Type: Product
Name: ZFP Therapeutic
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Sangamo BioSciences Announces Public Offering Of Common Stock

By a News Reporter-Staff News Editor at Investment Weekly News -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that it has commenced a $100 million underwritten public offering of shares of its common stock. All of the shares in the offering are ... [Published HispanicBusiness.com - Mar 27 2014]
First reported Mar 24 2014 - Updated Mar 25 2014 - 2 reports

Sangamo BioSciences Reports Public Offering of Common Stock

Sangamo BioSciences, Inc. announced that it has commenced a $100 million underwritten public offering of shares of its common stock. According to a release, all of the shares in the offering are to be sold by Sangamo. Sangamo intends to grant the underwriters ... [Published Individual.com - Mar 25 2014]
First reported Mar 20 2014 - Updated Mar 21 2014 - 3 reports

Sangamo BioSciences prices public offering of 4.44m common shares

(M2 EQUITYBITES via COMTEX) --DNA-binding protein company Sangamo BioSciences (NasdaqGS:SGMO) said on Thursday that it has priced a public offering of 4,444,444 common shares.The company has priced the offering to the public at USD22.50 per share for ... [Published TradingCharts.com - Mar 21 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Sangamo BioSciences expects USD100m from public offering of common shares

Mar 20, 2014 (Menafn - M2 EQUITYBITES via COMTEX) --DNA-binding protein company Sangamo BioSciences (nasdaqgs:SGMO) disclosed on Wednesday the start of a USD100m public offering ... [Published MENAFN - Mar 20 2014]
First reported Feb 26 2014 - Updated Feb 27 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 Cowen And Company Health Care Conference

RICHMOND, Calif., Feb. 26, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: General Business - Feb 26 2014]
First reported Feb 06 2014 - Updated Feb 06 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 Leerink Swann Global Healthcare Conference

RICHMOND, Calif., Feb. 6, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: Health - Feb 06 2014]

More Content

All (10) | News (8) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Sangamo BioSciences Announces Public Offering O... [Published HispanicBusiness.com - Mar 27 2014]
Sangamo BioSciences Reports Public Offering of ... [Published Individual.com - Mar 25 2014]
Sangamo BioSciences Posts Public Offering of Co... [Published Individual.com - Mar 24 2014]
Sangamo BioSciences prices public offering of 4... [Published TradingCharts.com - Mar 21 2014]
JP Morgan Securities leads Sangamo BioSciences ... [Published PredictWallStreet - Mar 21 2014]
Sangamo BioSciences Announces Pricing Of Public... [Published Reuters - Mar 20 2014]
Sangamo BioSciences expects USD100m from public... [Published MENAFN - Mar 20 2014]
Sangamo BioSciences Announces Public Offering O... [Published Scottrade - Mar 19 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Feb 26 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - Feb 06 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Feb 26 2014]
RICHMOND, Calif., Feb. 26, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - Feb 06 2014]
RICHMOND, Calif., Feb. 6, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.